VITILIGO

This study is testing whether adding a 6-month course of the drug methotrexate improves the results of a skin cell grafting procedure for adults with stable, treatment-resistant vitiligo on their elbows and knees. Researchers will compare two groups: one receives the drug before …

This study is testing a new topical powder form of the medication 5-Fluorouracil to treat vitiligo, a condition that causes loss of skin color. The powder is designed to fizz when mixed with water, which may help the medicine absorb better into the skin. Researchers will measure …

This early-stage study is testing an experimental drug called DR-01 in adults with alopecia areata (hair loss) or vitiligo (skin depigmentation). The main goal is to check the drug's safety and see if it shows any signs of helping regrow hair or restore skin color. Researchers wi…

This study compares two skin treatment methods—needling and microneedling—both followed by UVB light therapy, to see which works better for restoring skin color in people with stable vitiligo. Researchers will enroll 80 participants aged 15-60 who have had vitiligo for over a yea…

This study is testing if a low-dose steroid pill taken just two days a week can stop the spread of active vitiligo in children aged 4 to 9. Researchers will give the drug to 22 children for 3 months to see if it halts the skin condition and carefully monitor for side effects, wit…

This study is testing a surgical procedure that transplants a patient's own healthy skin cells into areas affected by vitiligo, aiming to restore skin color. It will enroll 30 people with stable vitiligo that hasn't responded well to medications or light therapy. Researchers will…

This study aims to see if a combination treatment using tiny needles (microneedling) and a cream called 5FU works better than a strong steroid cream for repigmenting small patches of vitiligo. It will involve 40 people with stable vitiligo covering less than 10% of their body. Re…

This study aims to understand what makes a topical cream called ruxolitinib more or less effective for people with vitiligo, a condition that causes white patches on the skin. Researchers will follow 170 patients in a real-world setting for 24 weeks to see which patient character…

This is an early-stage study to test the safety and initial effectiveness of an experimental gel called CGB-600 for treating vitiligo on the face and neck. It will involve 36 adults who will apply the gel or a placebo twice daily for 24 weeks. The main goals are to see if the tre…

This study is testing whether using ultrasound waves can help a steroid cream work better for treating vitiligo, a condition that causes white patches on the skin. Researchers will enroll 60 people with vitiligo to see if this combined approach improves skin repigmentation. The g…

This study is testing an investigational drug called FB102 to see if it is safe and can help restore skin color in adults with non-segmental vitiligo. About 64 participants will be randomly assigned to receive either FB102 or a placebo (an inactive substance) for comparison. Rese…

This study is creating a large registry of patients with conditions like eczema, psoriasis, and alopecia areata to track how treatments work in real-world settings. Researchers will follow 15,000 adults and children over time to understand treatment safety, effectiveness, and how…